Tibsovo

Indicated For

IDH1-mutated AML, cholangiocarcinoma

About This Medication

# ServierONE Patient Support Program Patient Guide: How to Get Tibsovo (ivosidenib) at Low or No Cost Tibsovo (ivosidenib) is a targeted oral therapy for adults with certain types of **acute myeloid leukemia (AML)** who have an **IDH1 mutation**, helping to block abnormal proteins that drive cancer growth.[4] The **ServierONE Patient Support Program** from Servier Pharmaceuticals offers financial assistance, including free medication through their Patient Assistance Program (PAP), copay help, and other support for eligible patients facing high costs.[7][4] ## Who Qualifies for the Program? This program helps **uninsured or underinsured patients** with income requirements, making Tibsovo more accessible.[1] Key eligibility includes: - A valid prescription for Tibsovo from your healthcare provider. - U.S. residency (proof required). - Meeting financial need based on household income (details below; contact program for exact thresholds).[1] - Not always excluding Medicare Part D patients, unlike some copay programs.[9][6] ServierONE connects patients to the right support: PAP for free meds if low-income/uninsured, copay assistance for commercially insured, or bridge programs during delays.[7] ## About Tibsovo (ivosidenib) **Tibsovo** is an FDA-approved IDH1 inhibitor tablet taken once daily. It's used alone or with other treatments for relapsed/refractory IDH1-mutant AML or newly diagnosed cases in patients 75+ or unfit for intensive chemotherapy.[4] Common side effects include fatigue, nausea, and differentiation syndrome (a serious reaction needing prompt medical care)—always discuss risks with your doctor. Before starting, inform your provider of all medications to avoid interactions.[4] ServierONE also offers nursing support, injection training (if needed for combos), and side effect reporting help. ## Income Eligibility Breakdown Income limits apply but aren't publicly fixed—patients report **annual gross pretax household income (AGI)** and household size on the form.[1] A Patient Experience Manager reviews eligibility, often up to **400-500% of the Federal Poverty Level (FPL)** for PAPs like this, though exacts require calling.[1] Contact ServierONE at **(800) 813-5905** for your situation. Here's a general FPL reference table (2026 guidelines; program may vary): | Household Size | 100% FPL | 400% FPL | 500% FPL | |---------------|----------|----------|----------| | 1 | $15,060 | $60,240 | $75,300 | | 2 | $20,440 | $81,760 | $102,200| | 3 | $25,820 | $103,280| $129,100| | 4 | $31,200 | $124,800| $156,000| *Add ~$5,380 per extra person for FPL.*[1] Provide docs like 1040, 1099, or Social Security statements.[1] Notes: "Income requirements apply; contact ServierONE for details." ## Insurance Requirements Available for **uninsured, underinsured, or commercially insured** patients; government programs like Medicare/Medicaid may limit copay aid but PAP can help.[9][6][7] Submit front/back insurance cards. If insured, include prior authorizations (PA) or appeal letters. Program bridges gaps during coverage denials.[3] ## Step-by-Step Application Process 1. **Discuss with Provider**: Ask your doctor to prescribe Tibsovo and complete enrollment.[4] 2. **Download/Get Form**: Use Tibsovo-specific form from servierone.com or call (800) 813-5905.[4][5] 3. **Fill Sections**: - Patient info (name, DOB, SSN, address, household size/income).[1] - Insurance details + copies of cards.[1][3] - Prescriber signs.[1] - Patient authorizes info sharing/signs consent.[3] 4. **Gather Docs**: Proof of income, residency (e.g., utility bill), prescription.[1] 5. **Submit**: Fax to **1-877-770-7102** or eEnroll online (physician eSigns).[4][5] Multiple methods available. 6. **Follow-Up**: Manager calls within **1 business day** if needed.[3] ## Timeline and Delivery Processing: Often **1-3 business days** for approval; manager contacts quickly.[3] Delivery: **Shipped free to patient home or doctor's office**.[1] Refills/reauthorization required periodically—program tracks.[1] ## Alternatives if Denied or Ineligible - **Appeal**: Resubmit with more docs or updated income.[1] - **Other PAPs**: RxAssist.org lists options; NeedyMeds for AML drugs.[9] - **Copay/Bridge**: If commercially insured, try QuickStart for instant copay cards.[7] - **State Programs**: Check Medicaid expansion or charity care. - **Generic/Biosimilars**: None for Tibsovo (unique IDH1 inhibitor).[ ] Call ServierONE for personalized navigation—they evaluate all options.[1] ## Important Disclaimer This guide summarizes ServierONE based on available info as of 2026; eligibility/rules change—**always verify directly at (800) 813-5905 or servierone.com**.[1][4] Not medical/financial advice. Consult your doctor for treatment suitability. Report side effects: 1-800-FDA-1088.[4] Servier may update programs; income thresholds aren't guaranteed here. (Word count: 942)

Program information last verified: March 30, 2026